BI Asset Management Fondsmaeglerselskab’s Tandem Diabetes Care TNDM Stock Holding History

BI Asset Management Fondsmaeglerselskab’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-8,433	Closed	-$1.27M	–	522
2021 Q4	$1.27M	Hold	8,433	–	–	0.05%	231
2021 Q3	$1.01M	Hold	8,433	–	–	0.04%	249
2021 Q2	$821K	Hold	8,433	–	–	0.03%	289
2021 Q1	$744K	Sell	8,433 -5,309	-39%	-$493K	0.03%	284
2020 Q4	$1.31M	Sell	13,742 -9,274	-40%	-$956K	0.06%	207
2020 Q3	$2.61M	Buy	23,016 +5,248	+30%	+$551K	0.12%	152
2020 Q2	$1.76M	Buy	+17,768	New	+$1.42M	0.09%	197
2020 Q1	–	Sell	-529	Closed	-$32K	–	386
2019 Q4	$32K	Sell	529 -142	-21%	-$8.76K	﹤0.01%	308
2019 Q3	$40K	Hold	671	–	–	﹤0.01%	354
2019 Q2	$43K	Buy	+671	New	+$43.3K	﹤0.01%	240

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab's TNDM Position: Q1 2022 in Review

BI Asset Management Fondsmaeglerselskab sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 8,433 shares — an estimated $1.27M sold.

BI Asset Management Fondsmaeglerselskab first reported a position in TNDM in Q2 2019 and held it in 10 quarters. The position peaked at $2.61M in Q3 2020. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

BI Asset Management Fondsmaeglerselskab reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
BI Asset Management Fondsmaeglerselskab sold 8,433 Tandem Diabetes Care shares in Q1 2022, an estimated $1.27M.
BI Asset Management Fondsmaeglerselskab first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 10 quarters.
BI Asset Management Fondsmaeglerselskab's Tandem Diabetes Care position peaked at $2.61M in Q3 2020.
379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on BI Asset Management Fondsmaeglerselskab's 13F filing for Q1 2022, filed 11 May 2022.